Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Liabilities and Shareholders Equity: 2020-2024

Historic Liabilities and Shareholders Equity for Universe Pharmaceuticals (UPC) over the last 5 years, with Sep 2024 value amounting to $68.0 million.

  • Universe Pharmaceuticals' Liabilities and Shareholders Equity rose 62.86% to $68.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $229.5 million, marking a year-over-year decrease of 5.56%. This contributed to the annual value of $68.0 million for FY2024, which is 62.86% up from last year.
  • Per Universe Pharmaceuticals' latest filing, its Liabilities and Shareholders Equity stood at $68.0 million for FY2024, which was up 62.86% from $41.7 million recorded in FY2023.
  • In the past 5 years, Universe Pharmaceuticals' Liabilities and Shareholders Equity ranged from a high of $70.1 million in FY2021 and a low of $28.8 million during FY2020.
  • For the 3-year period, Universe Pharmaceuticals' Liabilities and Shareholders Equity averaged around $56.4 million, with its median value being $59.5 million (2022).
  • In the last 5 years, Universe Pharmaceuticals' Liabilities and Shareholders Equity soared by 143.52% in 2021 and then decreased by 29.92% in 2023.
  • Universe Pharmaceuticals' Liabilities and Shareholders Equity (Yearly) stood at $28.8 million in 2020, then soared by 143.52% to $70.1 million in 2021, then fell by 15.12% to $59.5 million in 2022, then declined by 29.92% to $41.7 million in 2023, then soared by 62.86% to $68.0 million in 2024.